@ARTICLE{
author={Davies A,Mihaljevic Biljana S,Mercadal Santiago,Mihaylov G,Leppa S,Cotting D,Munoz FJ,Veenstra K,Berthillon N,Barrett M,MacDonald D},
year={2015},
title={Comparison of Subcutaneous and Intravenous Rituximab in the Maintenance Setting: Updated Safety Results of the Phase III Sabrina Study in Patients with Follicular Lymphoma},
journal={HAEMATOLOGICA},
volume={100},
number={},
pages={271-272},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Davies A,Merli Francesco,Mihaljevic Biljana S,Mercadal Santiago,Solal-Celigny Philippe,Boehnke Axel,Berge Claude,Cambon N,Macgregor L,Brewster M,Barrett M,MacDonald D},
year={2014},
title={Subcutaneous Rituximab and Chemotherapy Achieves Similar Overall Response Rates to Intravenous Rituximab in First-Line Follicular Lymphoma: Efficacy and Safety Results of the Phase Iii Sabrina Study},
journal={HAEMATOLOGICA},
volume={99},
number={},
pages={225-225},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Davies AJ,Merli Francesco,Mihaljevic Biljana S,Siritanaratkul Noppadol,Solal-Celigny Philippe,Boehnke Axel,Berge Claude,McIntyre Christine,Barrett M,MacDonald D},
year={2013},
title={Pharmacokinetics (PK), safety and overall response rate (ORR) achieved with subcutaneous (SC) administration of rituximab in combination with chemotherapy were comparable to those achieved with intravenous (IV) administration in patients (pts) with follicular lymphoma (FL) in the first-line setting: Stage 1 results of the phase III SABRINA study},
journal={BRITISH JOURNAL OF HAEMATOLOGY},
volume={161},
number={},
pages={7-8},
document_type={Meeting Abstract},
}